324 related articles for article (PubMed ID: 28770463)
1. Joint SNMMI-ASNC expert consensus document on the role of
Chareonthaitawee P; Beanlands RS; Chen W; Dorbala S; Miller EJ; Murthy VL; Birnie DH; Chen ES; Cooper LT; Tung RH; White ES; Borges-Neto S; Di Carli MF; Gropler RJ; Ruddy TD; Schindler TH; Blankstein R
J Nucl Cardiol; 2017 Oct; 24(5):1741-1758. PubMed ID: 28770463
[No Abstract] [Full Text] [Related]
2. Joint SNMMI-ASNC Expert Consensus Document on the Role of
Chareonthaitawee P; Beanlands RS; Chen W; Dorbala S; Miller EJ; Murthy VL; Birnie DH; Chen ES; Cooper LT; Tung RH; White ES; Borges-Neto S; Di Carli MF; Gropler RJ; Ruddy TD; Schindler TH; Blankstein R;
J Nucl Med; 2017 Aug; 58(8):1341-1353. PubMed ID: 28765228
[No Abstract] [Full Text] [Related]
3. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol.
Christopoulos G; Jouni H; Acharya GA; Blauwet LA; Kapa S; Bois J; Chareonthaitawee P; Rodriguez-Porcel MG
J Nucl Cardiol; 2021 Apr; 28(2):661-671. PubMed ID: 31111450
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET and MIBI-Tc SPECT as follow-up tools in a patient with cardiac sarcoidosis requiring a pacemaker.
Smedema JP; White L; Klopper AJ
Cardiovasc J Afr; 2008; 19(6):309-10. PubMed ID: 19104727
[TBL] [Abstract][Full Text] [Related]
5. [Cardiac sarcoidosis detected by FDG-PET].
Goto K; Okamoto E; Morita M; Sasamoto T; Endo M; Umezawa K; Suguta M; Kaneko Y; Nakano A; Arai M; Hasegawa A; Kurabayashi M
Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1396-8. PubMed ID: 16097596
[No Abstract] [Full Text] [Related]
6. The Utility of Whole Body
Giudicatti L; Marangou J; Nolan D; Dembo L; Baumwol J; Dwivedi G
Heart Lung Circ; 2020 Jan; 29(1):e1-e6. PubMed ID: 31501049
[TBL] [Abstract][Full Text] [Related]
7. Proliferation imaging with
Minamimoto R; Hotta M; Hiroe M; Awaya T; Nakajima K; Okazaki O; Yamashita H; Kaneko H; Hiroi Y
J Nucl Cardiol; 2021 Apr; 28(2):752-755. PubMed ID: 32052294
[No Abstract] [Full Text] [Related]
8. The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis.
Mc Ardle BA; Leung E; Ohira H; Cocker MS; deKemp RA; DaSilva J; Birnie D; Beanlands RS; Nery PB
J Nucl Cardiol; 2013 Apr; 20(2):297-306. PubMed ID: 23288545
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis.
Kim SJ; Pak K; Kim K
J Nucl Cardiol; 2020 Dec; 27(6):2103-2115. PubMed ID: 30603894
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Sarcoidosis.
Mankad P; Mitchell B; Birnie D; Kron J
Curr Cardiol Rep; 2019 Nov; 21(12):152. PubMed ID: 31768666
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Sarcoidosis Concomitant with Large-vessel Aortitis Detected by
Higuchi Y; Kimoto Y; Tanoue R; Tokunou T; Tomonari K; Maeda T; Horiuchi T
Intern Med; 2018 Jun; 57(11):1601-1604. PubMed ID: 29321427
[TBL] [Abstract][Full Text] [Related]
12. 68Ga-DOTATOC PET for Treatment Efficacy Evaluation of Cardiac Sarcoidosis.
Imperiale A; Poindron V; Martinez M; Ohlmann P; Schindler TH; El Ghannudi S
Clin Nucl Med; 2020 Sep; 45(9):e416-e418. PubMed ID: 32604122
[TBL] [Abstract][Full Text] [Related]
13. Acute inflammatory pericarditis secondary to cardiac sarcoidosis evaluated by 18F-fluorodeoxyglucose PET/CT imaging.
AlBassam O; Redwood T; Bowers N; Iwanochko R
J Nucl Cardiol; 2021 Apr; 28(2):763-767. PubMed ID: 32095937
[No Abstract] [Full Text] [Related]
14.
Bourque JM; Birgersdotter-Green U; Bravo PE; Budde RPJ; Chen W; Chu VH; Dilsizian V; Erba PA; Gallegos Kattan C; Habib G; Hyafil F; Khor YM; Manlucu J; Mason PK; Miller EJ; Moon MR; Parker MW; Pettersson G; Schaller RD; Slart RHJA; Strom JB; Wilkoff BL; Williams A; Woolley AE; Zwischenberger BA; Dorbala S
Heart Rhythm; 2024 May; 21(5):e1-e29. PubMed ID: 38466251
[TBL] [Abstract][Full Text] [Related]
15. PET/CT Evaluation of Cardiac Sarcoidosis.
Bois JP; Muser D; Chareonthaitawee P
PET Clin; 2019 Apr; 14(2):223-232. PubMed ID: 30826020
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis.
Flores RJ; Flaherty KR; Jin Z; Bokhari S
J Nucl Cardiol; 2020 Dec; 27(6):2003-2010. PubMed ID: 30421379
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of
Manabe O; Koyanagawa K; Hirata K; Oyama-Manabe N; Ohira H; Aikawa T; Furuya S; Naya M; Tsujino I; Tomiyama Y; Otaki Y; Anzai T; Tamaki N
JACC Cardiovasc Imaging; 2020 Apr; 13(4):1096-1097. PubMed ID: 31954654
[No Abstract] [Full Text] [Related]
18. 18F-FDG PET scan as follow-up tool for sarcoidosis with symptomatic cardiac conduction disturbances requiring a pacemaker.
Györik S; Ceriani L; Menafoglio A; Gallino A; Wyttenbach R
Thorax; 2007 Jun; 62(6):560. PubMed ID: 17536038
[No Abstract] [Full Text] [Related]
19.
Bour
